BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28374143)

  • 1. DNA damage response and hematological malignancy.
    Takagi M
    Int J Hematol; 2017 Sep; 106(3):345-356. PubMed ID: 28374143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA damage response pathway in normal hematopoiesis and malignancies.
    Delia D; Mizutani S
    Int J Hematol; 2017 Sep; 106(3):328-334. PubMed ID: 28707218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
    Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
    Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression variations of DNA damage response genes ATM and ATR in blood cancer patients.
    Parvez A; Mahjabeen I; Mehmood A; Khan AU; Nisar A; Kayani MA
    Mol Genet Genomics; 2023 Sep; 298(5):1173-1183. PubMed ID: 37338595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage response and disorders with hematology, oncology and immunology.
    Mizutani S
    Int J Hematol; 2017 Sep; 106(3):326-327. PubMed ID: 28699030
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies.
    Kwok M; Agathanggelou A; Stankovic T
    Blood; 2024 May; 143(21):2123-2144. PubMed ID: 38457665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assaying Radiosensitivity of Ataxia-Telangiectasia.
    Hu H; Nahas S; Gatti RA
    Methods Mol Biol; 2017; 1599():1-11. PubMed ID: 28477107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA damage response and hematological malignancy].
    Takagi M
    Rinsho Ketsueki; 2010 Jul; 51(7):539-45. PubMed ID: 20693774
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
    Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
    Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic vulnerabilities upon inhibition of DNA damage response.
    Wang C; Tang M; Chen Z; Nie L; Li S; Xiong Y; Szymonowicz KA; Park JM; Zhang H; Feng X; Huang M; Su D; Hart T; Chen J
    Nucleic Acids Res; 2021 Aug; 49(14):8214-8231. PubMed ID: 34320214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-telangiectasia and cellular responses to DNA damage.
    Meyn MS
    Cancer Res; 1995 Dec; 55(24):5991-6001. PubMed ID: 8521380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.
    Riabinska A; Daheim M; Herter-Sprie GS; Winkler J; Fritz C; Hallek M; Thomas RK; Kreuzer KA; Frenzel LP; Monfared P; Martins-Boucas J; Chen S; Reinhardt HC
    Sci Transl Med; 2013 Jun; 5(189):189ra78. PubMed ID: 23761041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Damage Response Signals Transduce Stress From Rheumatoid Arthritis Risk Factors Into T Cell Dysfunction.
    Shao L
    Front Immunol; 2018; 9():3055. PubMed ID: 30619377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
    Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
    Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM Mutations in Cancer: Therapeutic Implications.
    Choi M; Kipps T; Kurzrock R
    Mol Cancer Ther; 2016 Aug; 15(8):1781-91. PubMed ID: 27413114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar responses to DNA double-strand breaks.
    Larsen DH; Stucki M
    Nucleic Acids Res; 2016 Jan; 44(2):538-44. PubMed ID: 26615196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
    Chou WC; Hu LY; Hsiung CN; Shen CY
    Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy.
    Vecchio D; Frosina G
    Curr Drug Targets; 2016; 17(2):139-53. PubMed ID: 25382204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM9 deficiency delays primordial germ cell proliferation independent of the ATM pathway.
    Luo Y; Schimenti JC
    Genesis; 2015 Nov; 53(11):678-84. PubMed ID: 26388201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in ataxia telangiectasia.
    Watters DJ
    Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.